Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myelomaKevin R. Kelly, Steffan T. Nawrocki, Claudia M. Espitia et al.|Oncogene|2011Cited by 80
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancerJennifer S. Carew, Steffan T. Nawrocki, Claudia M. Espitia et al.|Cell Death and Disease|2013Cited by 69
The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancerDevalingam Mahalingam, Steffan T. Nawrocki, Sukeshi Patel Arora et al.|BMC Cancer|2015Cited by 19
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib TrialSteffan T. Nawrocki, Kevin R. Kelly, Julian Olea et al.|Clinical Cancer Research|2023Cited by 13
Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple MyelomaKevin R. Kelly, Steffan T. Nawrocki, Kaijin Wu et al.|Blood|2016Cited by 9